We found that TRAIL-R1+ cells had significantly higher rate of tumor formation after serial adoptive transplantations, compared to TRAIL-R1- cells, based on bioluminescence examination (Figure 5A–5B). The gene discussed is TNFRSF10A; the disease is neoplasm.